The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.38 billion in 2028 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (ai) and data analytics, expansion in glycobiology-based drug development, integration of glycomics in disease biomarker discovery, personalized medicine and glycan-based therapeutics. Major trends in the forecast period include cross-disciplinary collaborations, glycosylation patterns in disease mechanisms, innovative precision medicine and personalized therapies, advancements in glycoanalytical tools, glycans in immunotherapy and vaccines.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report
Scope Of Glycomics or Glycobiology Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Glycomics or Glycobiology Market Overview
Market Drivers –
The increase in demand for medicines for the treatment of several severe chronic diseases is expected to propel the growth of the glycomics or glycobiology market going forward. Chronic diseases are health problems that are usually long-term and can be controlled but not healed. A glycomics study studies changes in glycosylation and its functions, which helps in the development of drugs and related medications for several severe chronic diseases. For instance, in 2022, according to Cancer Facts and Figures 2022–2024, a scientific paper by the American Cancer Society, there would be 22.5 million cancer (a chronic disease) survivors by 2032, which is projected to reach 26 million by 2040. Thus, the increase in demand for medicines for the treatment of several severe chronic diseases drives the glycomics or glycobiology market.
Market Trends –
Investments in research and development activities are a key trend gaining popularity in the glycomics or glycobiology market. Major research and development institutions are funding research centers for glycobiology, aiming for the research and development of glycomics or glycobiology. For instance, in August 2022, Griffith University, an Australia-based Institute for Glycomics, launched the ACRF International Centre for Cancer Glycomics with a $2.6 million ACRF grant that is dedicated to achieving cancer glycocoding. This is a unique facility, with a better understanding of the glycocode that leads to the translation of novel discoveries and clinical outcomes that would help cancer patients improve their lives.
The glycomics or glycobiology market covered in this report is segmented –
1) By Product: Enzymes, Kits, Reagents and Chemicals, Instruments, Carbohydrates
2) By Application: Drug Discovery and Development, Disease Diagnostics, Other Applications
3) By End-user: Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories
Get an inside scoop of the glycomics or glycobiology market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=8749&type=smp
Regional Insights –
North America was the largest region in the glycomics or glycobiology market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the glycomics or glycobiology market report are Water Corporation, Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., S-BIO Pte. Ltd., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., Sumitomo Bakelite Co. Ltd., Bruker Corporation, AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., IEC Group Ltd., R&D Systems Inc.
Table of Contents
1. Executive Summary
2. Glycomics or Glycobiology Market Report Structure
3. Glycomics or Glycobiology Market Trends And Strategies
4. Glycomics or Glycobiology Market – Macro Economic Scenario
5. Glycomics or Glycobiology Market Size And Growth
…..
27. Glycomics or Glycobiology Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Read Related Topics:
https://goodprnews.com/data-center-power-market-size/
https://topprnews.com/digestive-and-intestinal-remedies-market-share/
https://topprnews.com/dna-and-gene-chip-market-size/
https://topprnews.com/data-center-power-market-growth/
https://goodprnews.com/digestive-and-intestinal-remedies-market-size/
https://goodprnews.com/dna-and-gene-chip-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
